コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ough linked protein domains (e.g. TALENs and zinc-finger nucleases).
2 th activity on par with a homodimeric Zif268 zinc-finger nuclease.
3 we compared with the well-established 'QQR' zinc-finger nuclease.
4 ogenous Ig loci were silenced using designer zinc finger nucleases.
5 on of alpha or beta TCR chains with designer zinc finger nucleases.
6 integrating RNA destabilizing elements using zinc finger nucleases.
7 a cells by targeted mutation of exon 8 using zinc finger nucleases.
8 t HIV Rev protein M10, fusion inhibitors and zinc-finger nucleases.
9 ation can now be reliably accomplished using zinc-finger nucleases.
13 er other sequence-specific nucleases, namely zinc finger nucleases and meganucleases, lies in their e
14 to other customizable endonucleases, such as zinc finger nucleases and transcription activator-like e
15 efficiencies similar to those obtained using zinc finger nucleases and transcription activator-like e
16 Tev-LHEs are distinct from the FokI-derived zinc-finger nuclease and TAL effector nuclease platforms
18 ed the Plasmodium falciparum K13 locus using zinc-finger nucleases and measured ring-stage survival r
19 ccurring nucleases, including meganucleases, zinc finger nucleases, and transcription activator-like
20 porter gene carried a recognition site for a zinc-finger nuclease, and protoplasts from each tobacco
25 codons and exerting control by microRNAs or zinc finger nucleases--are providing new ways of control
26 g DSBs (5' DSBs) in yeast using an optimized zinc finger nuclease at an efficiency that approached HO
30 double-strand break induced by the resulting zinc-finger nuclease can create specific sequence altera
32 n vivo applications and to determine whether zinc finger nucleases create undesired genomic instabili
35 rat expressing the G551D variant obtained by zinc finger nuclease editing of a human complementary DN
37 assist selection of rare targeted clones and zinc finger nucleases engineered to specifically stimula
38 ial fingers can be used to create functional zinc finger nucleases for editing vertebrate genomes.
41 ctivator-like effector protein nuclease, and zinc finger nuclease gene editing strategies to either d
42 emonstrate that chromosome breaks created by zinc-finger nucleases greatly enhance the frequency of l
46 as an anticancer strategy, we disrupted, via zinc finger nucleases, MCT4 and BASIGIN genes in colon a
49 d mitochondrial DNA (mtDNA) damage and after zinc finger nuclease-mediated gene mutation correction,
55 as motor and behavioural function in a novel zinc-finger nuclease model of RTT utilizing both male an
57 strate that temporally optimized delivery of zinc finger nuclease mRNA via electroporation and adeno-
59 ns and in cells genetically engineered using zinc-finger nucleases, single-nucleotide changes occur f
60 ry and development of DNA-editing nucleases (Zinc Finger Nucleases, TALENs, CRISPR/Cas systems) has g
61 s this, gene-editing technologies, including zinc-finger nucleases, TALENs, CRISPR-Cas, base editing,
62 ines made deficient in O-glycan extension by zinc finger nuclease targeting of a key gene in O-glycan
65 developed a novel Bace1(-/-) rat line using zinc-finger nuclease technology and compared Bace1(-/-)
68 from several breast cancer cell lines using Zinc-Finger Nuclease technology, which resulted in drast
71 are other potential biotechnologies, such as zinc finger nucleases, that could be also used for trans
78 ogies for facile manipulation of the genome (zinc finger nucleases, transcription activator-like effe
80 e mainstream genome editing tools, including zinc finger nucleases, transcription activator-like effe
82 ologies are rapidly evolving, from the early zinc-finger nucleases, transcription activator-like effe
83 t expression of sequence-specific nucleases (zinc-finger nucleases, transcription activator-like effe
84 go, first with meganucleases and followed by zinc finger nucleases, transcriptional activator-like ef
86 genome editing proteins, Cre recombinase and zinc-finger nucleases, under conditions in which (-30)GF
92 o wild-type (MSTN(+/+) ) rats, rats in which zinc finger nucleases were used to genetically inactivat
93 ome of the Dahl Salt-sensitive (S) rat using zinc-finger nucleases, wherein the mutant rat had a 17 b
94 ccelerated site-specific DNA cleavage by the zinc-finger nuclease, without enhancing off-target cleav
95 ement therapies that addresses these issues: zinc finger nuclease (ZFN) -mediated site-specific integ
96 activator-like effector nuclease (TALEN) and zinc finger nuclease (ZFN) can be engineered into site-s
98 activator-like effector nuclease (TALEN) and zinc finger nuclease (ZFN) genome editing technology ena
100 we report that combining electroporation of zinc finger nuclease (ZFN) mRNA with donor template deli
103 s to develop RNA-based approaches to deliver zinc finger nuclease (ZFN), evaluate the effect of CCR5
104 FP respectively) by targeted integration via zinc finger nuclease (ZFN)--mediated homologous recombin
106 past two years, advances in transposon- and zinc finger nuclease (ZFN)-mediated gene knockout as wel
108 ate a method for ligand-mediated delivery of zinc finger nucleases (ZFN) proteins using transferrin r
110 are genetically modified with mRNA encoding zinc finger nucleases (ZFN) that target and disrupt a sp
111 ryonic stem cell (ESC)-based gene targeting, zinc-finger nuclease (ZFN) and transcription activator-l
112 liver-targeted in vivo genome editing using zinc-finger nuclease (ZFN) technology to insert the huma
116 three genes in human pluripotent cells using zinc-finger nuclease (ZFN)-mediated genome editing.
119 no-associated virus (AAV) vector delivery of zinc finger nucleases (ZFNs) and corrective donor templa
120 vectors by using a combination of engineered zinc finger nucleases (ZFNs) and homing endonucleases.
122 ering sequence-specific nucleases, including zinc finger nucleases (ZFNs) and TAL effector nucleases
124 ablished a broadly applicable strategy using zinc finger nucleases (ZFNs) and transcription activator
130 ed double-strand break induced by engineered zinc finger nucleases (ZFNs) can stimulate integration o
133 on of genomic double-strand breaks (DSBs) by zinc finger nucleases (ZFNs) has been deployed for gene
138 The first truly targetable reagents were the zinc finger nucleases (ZFNs) showing that arbitrary DNA
139 off-target site for the extensively studied zinc finger nucleases (ZFNs) targeting C-C chemokine rec
140 an approach for improving the specificity of zinc finger nucleases (ZFNs) that engineers the FokI cat
141 stability in mammalian systems, we developed zinc finger nucleases (ZFNs) that recognize and cleave C
142 by the transient expression of CCR5-targeted zinc finger nucleases (ZFNs) to generate CCR5-negative c
144 ds for identifying the off-target effects of zinc finger nucleases (ZFNs) were described-one using an
147 n or correction, based on the development of zinc finger nucleases (ZFNs), transcription activator-li
148 iew, we introduce the three central methods, zinc finger nucleases (ZFNs), transcription activator-li
150 dopsis genes through regulated expression of zinc finger nucleases (ZFNs)-enzymes engineered to creat
154 relies on cleavage of the target by designed zinc-finger nucleases (ZFNs) and production of a linear
158 of engineered site-directed nucleases, like zinc-finger nucleases (ZFNs) and transcription activator
167 ly, we and others have shown that customized zinc-finger nucleases (ZFNs) can introduce targeted fram
181 olution to this problem: the use of designed zinc-finger nucleases (ZFNs) that induce a double-strand
182 d genetic engineering of this parasite using zinc-finger nucleases (ZFNs) that produce a double-stran
185 -resistant genotype de novo using engineered zinc-finger nucleases (ZFNs) to disrupt endogenous CCR5.
188 gene-targeting approach in the monarch using zinc-finger nucleases (ZFNs), engineered nucleases that
189 s strains (including wild-type CC-125) using zinc-finger nucleases (ZFNs), genetically encoded CRISPR
191 uding homing endonucleases or meganucleases, zinc-finger nucleases (ZFNs), TAL effector nucleases (TA
194 ree classes of targetable cleavage reagents: zinc-finger nucleases (ZFNs), transcription activator-li
196 to enable such high-precision targeting with zinc-finger nucleases (ZFNs), we have developed an expan
197 rgeting in mice using embryonic injection of zinc-finger nucleases (ZFNs), which generate site-specif
198 To stably modify this organism, we used zinc-finger nucleases (ZFNs), which take advantage of ho